With the 10th AMR Conference – Novel Antimicrobials, Diagnostics & Vaccines in Basel just around the corner (3–4 March), we’re looking forward to being back in the room where some of the most important antimicrobial resistance conversations are happening.

AMR isn’t a distant threat anymore. It’s present, evolving, and increasingly complex. Which means the science, the data, and the collaboration behind it have to evolve too.

At Micron, our focus has always been practical as much as scientific — supporting anti-infective development through deep AMR expertise, global trial delivery, advanced microbiology, and integrated data capabilities. From surveillance insights to complex infectious disease trials, we’ve been working quietly (and sometimes intensely) behind the scenes to help sponsors navigate this space with confidence.

Basel gives us the opportunity to step out from behind the spreadsheets and protocols for a moment. To exchange ideas. To challenge assumptions. To listen carefully to where the field is heading next — and, perhaps, where it needs to move faster.

We’ll be sharing more soon about who will be attending and how to connect with us during the conference.